Home » Topics » BioWorld Science

BioWorld Science
RSS

Shanghai GeneChem synthesizes anti-CLDN128.2 antibodies

May 11, 2020

New MAP3K5 inhibitors discovered at CJ HealthCare

May 11, 2020

New phase I trial evaluates gene therapy to treat severe hemophilia A

May 11, 2020

Boehringer Ingelheim identifies new NR2B receptor negative allosteric modulators

May 11, 2020

Cell competition links hyperinsulinemia to cancer

May 11, 2020

First-in-human results presented for SLC-0111 in advanced solid tumors

May 11, 2020

SNYE1 mutations associated with cerebellar ataxia and generalized dystonia

May 11, 2020

Health Canada grants approval for phase II study of LSALT peptide in patients with COVID-19

May 11, 2020

FDA clears IND application for phase II study of PLX cells in severe COVID-19

May 11, 2020

FDA approves IND for phase IIa study of opaganib for COVID-19

May 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...